In EECs, RGS, specifically RGS9, may modulate the secretion of nutrient-stimulated GPCR-mediated GLP-1 and PYY from gut L cells, and this system may serve as a potential target for the pharmacological treatment of obesity. This evidence concerns the gene PYY and obesity due to melanocortin 4 receptor deficiency.